Trastuzumab Intravenous: Uses, Side Effects, Interactions

Trastuzumab Intravenous: Uses, Side Effects, Interactions trastuzumab Trastuzumab exerts an antitumour activity and is used in the treatment of HER2-positive breast cancer HER2 protein overexpression is observed in 20%-30% of trastuzumab Descriptions Trastuzumab injection is used to treat HER2-overexpressing new or metastatic breast cancer It can be

trastuzumab Key Message The ShortHER trial failed to demonstrate the non-inferiority of 9 weeks versus 1 year of adjuvant trastuzumab combined with chemotherapy The short

trastuzumab Subcutaneous trastuzumab has a similar safety profile to intravenous trastuzumab and is non-inferior in terms of pharmacokinetic profile and efficacy and Comment: Trastuzumab is a humanized IgG1κ monoclonal antibody targeting HER2 Annotated peptide sequences for this antibody are available from its IMGTmAb-DB